The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns
1 other identifier
interventional
48
1 country
1
Brief Summary
In burn patients, the wound healing process may lead to a fibrotic hypertrophic scar, which is raised, inflexible and responsible functional impairments. There are few studies which have investigated the effect of extracorporeal shock wave therapy (ESWT) on hypertrophic scar characteristics using objective measurements. Thus, this study aimed to ascertain the effects of ESWT on burn scars using objective measurements. This double-blinded, randomized, controlled trial involved 36 patients with burns. Patients were randomized into a ESWT (an energy flux density (EFD) of 0.05 to 0.30 mJ/mm2, frequency of 4Hz, and 1000 to 2000 impulses) or a sham stimulation group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 9, 2020
CompletedStudy Start
First participant enrolled
April 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2020
CompletedJune 4, 2020
June 1, 2020
2 months
April 2, 2020
June 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
scar thickness
The thickness was measured with a ultrasonic wave equipment
4 weeks
Secondary Outcomes (5)
skin darkness
4 weeks
skin reddness
4 weeks
skin dryness
4 weeks
sebum level
4 weeks
Elasticity
4 weeks
Study Arms (2)
Extracorporeal shock wave therapy group
EXPERIMENTALPatients in the ESWT group were explained to select the most hypertrophic and retracting area for the treatment on dominant hand. ESWT was conducted using the Duolith SD-1® device (StorzMedical, Tägerwilen, Switzerland) with an electromagnetic cylindrical coil source for the focused shock wave (Fig. 2). ESWT was performed around the primary treatment site at 100 impulses/cm2, an energy flux density(EFD) of 0.05 to 0.30 mJ/mm2, frequency of 4Hz, and 1000 to 2000 impulses were administered at 1-week intervals for 4 sessions.
sham stimulation group
SHAM COMPARATORThe same shock wave equipment used in the experimental group was used with a sham adapter that had the same shape but emitted no energy
Interventions
ESWT was conducted using the Duolith SD-1® device (StorzMedical, Tägerwilen, Switzerland) with an electromagnetic cylindrical coil source for the focused shock wave (Fig. 2). ESWT was performed around the primary treatment site at 100 impulses/cm2, an energy flux density(EFD) of 0.05 to 0.30 mJ/mm2, frequency of 4Hz, and 1000 to 2000 impulses were administered at 1-week intervals for 4 sessions.
Standard accupational therapy consist of range of motion exercise, strengthening exercises, and activities of daily living exercises
Eligibility Criteria
You may qualify if:
- aged ≥18 years
- deep partial-thickness (second-degree) burn or a full thickness (third-degree) burn
- less than 6 months since the onset of the burn injury
You may not qualify if:
- history of cancer
- fourth-degree burns (involving muscles, tendons, and bone injuries)
- musculoskeletal diseases (fracture, amputation, rheumatoid arthritis, and degenerative joint diseases)
- pregnancy
- if there was potential for additional damage to the skin due to the use of ESWT and conventional occupational therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hangang Sacred Heart Hospital
Seoul, Yeong-deungpo-Dong, 150-719, South Korea
Related Publications (2)
Cui HS, Hong AR, Kim JB, Yu JH, Cho YS, Joo SY, Seo CH. Extracorporeal Shock Wave Therapy Alters the Expression of Fibrosis-Related Molecules in Fibroblast Derived from Human Hypertrophic Scar. Int J Mol Sci. 2018 Jan 2;19(1):124. doi: 10.3390/ijms19010124.
PMID: 29301325RESULTSaggini R, Saggini A, Spagnoli AM, Dodaj I, Cigna E, Maruccia M, Soda G, Bellomo RG, Scuderi N. Extracorporeal Shock Wave Therapy: An Emerging Treatment Modality for Retracting Scars of the Hands. Ultrasound Med Biol. 2016 Jan;42(1):185-95. doi: 10.1016/j.ultrasmedbio.2015.07.028. Epub 2015 Oct 9.
PMID: 26454624RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- 1. The patients didnot know whether it is included in the experimental group and control group 2. Outcome measurements and data analyses were performed by a trained and blinded outcome assessor who was not involved in the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical professor
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 9, 2020
Study Start
April 15, 2020
Primary Completion
May 31, 2020
Study Completion
May 31, 2020
Last Updated
June 4, 2020
Record last verified: 2020-06